UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 906,304 shares of the company's stock after buying an additional 13,618 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.73% of Henry Schein worth $62,716,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Smartleaf Asset Management LLC grew its stake in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares in the last quarter. Guggenheim Capital LLC grew its position in shares of Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after purchasing an additional 159 shares in the last quarter. CIBC Asset Management Inc increased its holdings in shares of Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after purchasing an additional 169 shares during the last quarter. Metis Global Partners LLC lifted its position in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after buying an additional 187 shares in the last quarter. Finally, Sanctuary Advisors LLC boosted its stake in Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after buying an additional 203 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Down 0.4%

Henry Schein stock traded down $0.26 during mid-day trading on Wednesday, reaching $73.40. 1,299,615 shares of the company's stock were exchanged, compared to its average volume of 1,664,262. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a market cap of $8.93 billion, a P/E ratio of 30.21, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a fifty day moving average of $67.54 and a 200-day moving average of $71.58.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue for the quarter was down .1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.10 EPS. Sell-side analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Activity at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent analyst reports. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Barrington Research decreased their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. UBS Group dropped their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Finally, Piper Sandler decreased their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.